The global non-metastatic prostate cancer treatment market is a growing sector within the healthcare industry. Driven by an increasing prevalence of prostate cancer, coupled with advancements in diagnostic methods, this market is poised for significant growth. Major players in the market are actively investing new therapies and treatment options to